Article info

Download PDFPDF
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

Authors

  1. Correspondence to Professor Günter Emons, Universitätsmedizin Göttingen, Gottingen, Germany; emons{at}med.uni-goettingen.de
View Full Text

Citation

Emons G, Kim J, Weide K, et al
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

Publication history

  • Accepted May 19, 2021
  • First published July 5, 2021.
Online issue publication 
July 05, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.